Publicacions destacades

• Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington's Disease

  Rodríguez-Urgellés, E; Casas-Torremocha, D; Sancho-Balsells, A; Ballasch, I; García-García, E;

  (...)

  Rodríguez, MJ; Bortolozzi, A; Sanchez-Vives, MV; Giralt, A; Alberch, J.

  Veure llistat complet d'autors

  Referència:

  Cellular And Molecular Life Sciences 2023.

• iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

  Tristán-Noguero, A; Fernández-Carasa, I; Calatayud, C; Bermejo-Casadesús, C; Pons-Espinal, M;

  (...)

  Pineda, M; Artuch, R; Raya, A; García-Cazorla, A; Consiglio, A.

  Veure llistat complet d'autors

  Referència:

  Embo Molecular Medicine 2023.

• The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features

  Miquel-Rio, L; Sarriés-Serrano, U; Pavia-Collado, R; Meana, JJ; Bortolozzi, A;

  Referència:

  Biomedicines 2023.

• Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease

  Duperrier, S; Bortolozzi, A; Sgambato, V;

  Referència:

  International Journal Of Molecular Sciences 2022.

• Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype

  Miquel-Rio, L; Alarcón-Arís, D; Torres-López, M; Cóppola-Segovia, V; Pavia-Collado, R;

  (...)

  Montefeltro, A; Vila, M; Artigas, F; Revilla, R; Bortolozzi, A.

  Veure llistat complet d'autors

  Referència:

  Translational Psychiatry 2022.

• Corrigendum to "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys" [EBioMedicine 2020; 59:102944]

  Alarcon-Aris, Diana; Pavia-Collado, Ruben; Miquel-Rio, Lluis; Coppola-Segovia, Valentin; Ferres-Coy, Albert;

  (...)

  Montefeltro, Andres; Kordower, Jeffrey H; Vila, Miquel; Artigas, Francesc; Bortolozzi, Analia.

  Veure llistat complet d'autors

  Referència:

  Ebiomedicine 2021.

• Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease

  Bortolozzi, A; Artigas, F; Manashirov, S; Chen, A;

  Referència:

  Pharmacology & Therapeutics 2021.

• Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice

  Neus Fullana, M; Ruiz-Bronchal, Esther; Ferres-Coy, Albert; Juarez-Escoto, Elena; Artigas, Francesc;

  Bortolozzi, Analia.

  Referència:

  Glia 2019.

• Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis

  Carballo-Carbajal, Iria; Laguna, Ariadna; Romero-Gimenez, Jordi; Cuadros, Thais; Bove, Jordi;

  (...)

  Ballabio, Andrea; Hasegawa, Takafumi; Bortolozzi, Analia; Gelpi, Ellen; Vila, Miquel.

  Veure llistat complet d'autors

  Referència:

  Nature Communications 2019.